Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.17NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.3.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.3.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.3.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.3.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FZ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FZ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FZ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FZ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DV.7.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DV.7.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.7.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.7.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.30.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.30.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.30.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.30.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.68ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.68ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.68ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.68NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CD.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CD.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CD.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.122.3 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.122.3 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.122.3 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.122.3 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.132 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.132 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.132 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.132 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.160.17ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.160.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.160.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.160.17NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.4.1.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.4.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17982.1US
XBB.1.19ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used